Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothée Faille

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 6, 2026
Interlaboratory exercise on the use of immunofluorescence microscopy on the blood smear for recognizing inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelets in Health and DiseaseCarlo Zaninetti, Loredana Bury, Valeria Bozzi, et al.
Journal of Thrombosis and Haemostasis : JTH|May 18, 2024
The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopeniaCaroline Vayne, Jérôme Rollin, Rumi Clare, et al.
Blood Advances|February 22, 2024
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosisMarie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, et al.
Blood Advances|May 27, 2026
A comprehensive multicenter study assessing the impact of abelacimab, asundexian and milvexian on coagulation assaysLaurie Goubeau, Emmanuel Curis, Xavier Delavenne, et al.
Frontiers in Medicine|January 4, 2021
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World SettingNicolas Gendron, Richard Chocron, Paul Billoir, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2024
Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk studyNadine Ajzenberg, Dan Longrois, Dorothée Faille, et al.
Thrombosis and Haemostasis|June 24, 2020
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the LiteratureYves Gruel, Caroline Vayne, Jérôme Rollin, et al.
Mayo Clinic Proceedings|February 7, 2021
Arterial Thrombotic Events in Adult Inpatients With COVID-19Morgane Fournier, Dorothée Faille, Antoine Dossier, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2023
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet PhysiologyMarie-Christine Alessi, Carmen Coxon, Manal Ibrahim-Kosta, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|March 6, 2026
Interlaboratory exercise on the use of immunofluorescence microscopy on the blood smear for recognizing inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelets in Health and DiseaseCarlo Zaninetti, Loredana Bury, Valeria Bozzi, et al.
Journal of Thrombosis and Haemostasis : JTH|May 18, 2024
The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopeniaCaroline Vayne, Jérôme Rollin, Rumi Clare, et al.
Blood Advances|February 22, 2024
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosisMarie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, et al.
Blood Advances|May 27, 2026
A comprehensive multicenter study assessing the impact of abelacimab, asundexian and milvexian on coagulation assaysLaurie Goubeau, Emmanuel Curis, Xavier Delavenne, et al.
Frontiers in Medicine|January 4, 2021
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World SettingNicolas Gendron, Richard Chocron, Paul Billoir, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2024
Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk studyNadine Ajzenberg, Dan Longrois, Dorothée Faille, et al.
Thrombosis and Haemostasis|June 24, 2020
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the LiteratureYves Gruel, Caroline Vayne, Jérôme Rollin, et al.
Mayo Clinic Proceedings|February 7, 2021
Arterial Thrombotic Events in Adult Inpatients With COVID-19Morgane Fournier, Dorothée Faille, Antoine Dossier, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2023
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet PhysiologyMarie-Christine Alessi, Carmen Coxon, Manal Ibrahim-Kosta, et al.
Pageof 5